FERRING PHARMACEUTICALS INC.

Lobbying client · New Jersey · filed 2025 to 2026

biopharmaceutical company

$330,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (55802), not by name.

Firms hired 1

BROWNSTEIN HYATT FARBER SCHRECK, LLP $330,000 6 filings

Reported by year 2 years

2026 $100,000 2 filings
2025 $230,000 4 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

Executive Office of the President (EOP) 5
Commerce, Dept of (DOC) 4
HOUSE OF REPRESENTATIVES 4
U.S. Trade Representative (USTR) 4
SENATE 3
Bureau of Industry and Security (BIS) 1

Recent filings 6 total

Q2

BROWNSTEIN HYATT FARBER SCHRECK, LLP

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 20, 2026

View → Q1

BROWNSTEIN HYATT FARBER SCHRECK, LLP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $50,000 income · posted Apr 18, 2026

View → Q4

BROWNSTEIN HYATT FARBER SCHRECK, LLP

4th Quarter (Oct 1 - Dec 31) 2025 · House · $80,000 income · posted Jan 20, 2026

View → Q3

BROWNSTEIN HYATT FARBER SCHRECK, LLP

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $50,000 income · posted Oct 17, 2025

View → Q2

BROWNSTEIN HYATT FARBER SCHRECK, LLP

2nd Quarter (Apr 1 - June 30) 2025 · $50,000 income · posted Jul 17, 2025

View → Q1

BROWNSTEIN HYATT FARBER SCHRECK, LLP

1st Quarter (Jan 1 - Mar 31) 2025 · $50,000 income · posted Apr 18, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.